This study aimed to evaluate dynamic anti-phosphatidylserine/prothrombin (aPS/PT) and antiphospholipid (aPL) antibody changes in antiphospholipid syndrome-recurrent pregnancy loss (APS-RPL) patients and their relationship with pregnancy outcomes. The gene discussed is F2; the disease is autoimmune polyendocrinopathy.